Renal Cancer - Results from #2720

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date. July 10, 2020

Influence of border-age on survival of sporadic renal cell carcinoma: young adults versus octogenarians. July 10, 2020

Comparison of models of diffusion in Wilms' tumours and normal contralateral renal tissue. July 9, 2020

Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome. July 9, 2020

Atezolizumab-induced type 1 diabetes mellitus in a patient with metastatic renal cell carcinoma. July 9, 2020

Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database. July 9, 2020

Impact of Time-To-Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma. July 9, 2020

Stratification of cystic renal masses into benign and potentially malignant: applying machine learning to the bosniak classification. July 9, 2020

Prognostic Effect of Comorbid Disease and Immune Gene Expression on Mortality in Kidney Cancer-A Population Based Study. July 8, 2020

Immunotherapy-related skeletal muscle weakness in cancer patients: a case series. July 8, 2020

Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study. July 7, 2020

Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors. July 7, 2020

Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. July 7, 2020

Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer. July 7, 2020

An evaluation of the role of tumor load in cytoreductive nephrectomy. July 7, 2020

The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort. July 6, 2020

DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy. July 6, 2020

Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers. July 3, 2020

Resveratrol Inhibition of Renal Cancer Stem Cell Characteristics and Modulation of the Sonic Hedgehog Pathway. July 3, 2020

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes. July 3, 2020

Page 137 of 459